Work

Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful

Year: 2017

Type: article

Abstract: Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has emerged as the most important imaging tool to guide oncologists in the diagnosis, staging, response assessment, relapse/recurrence detection,and therapeutic decision making of DLBCL. Other imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and conventional radiography are also used in the evaluation of lymphoma. MRI is useful for nervous system and musculoskeletal system involvement and is emerging as a radiation free alternative to PET/CT. This article provides a comprehensive review of both the functional and morphological imaging modalities, available in the management of DLBCL.

Source: Korean Journal of Radiology

DOI: 10.3348/kjr.2017.18.1.54

Authors: Hina J. Shah, Abhishek R. Keraliya, Jyothi P. Jagannathan, Sree Harsha Tirumani, Vikram R. Lele, Pamela J. DiPiro

Institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Jaslok Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W2550352630